Paushak Ltd reported strong second-quarter results for the period ending September 30, 2026. The specialty chemicals manufacturer saw its revenue from operations surge 52% year-on-year to Rs 89.32 crore, while profit after tax climbed 57% to Rs 13.51 crore. Driven by operational expansion, the company’s half-yearly performance also remained robust with a 51% revenue increase.
Paushak Ltd Posts Strong Revenue and Profit Growth for Q2
Revenue for Q2 FY2027 reached Rs 89.32 crore, a 52% increase from the year-ago period.
Profit after tax rose to Rs 13.51 crore, reflecting a 57% jump compared to Q2 FY2026.
Reader Takeaway: Strong top-line and bottom-line expansion, though concentration in a single specialty chemical segment remains a key dependency.
What just happened
Paushak Ltd has released its unaudited financial results for the quarter and half-year ended September 30, 2026. The company reported a significant uptrend across all primary financial metrics, driven by scaling operations within its specialty chemicals business. Revenue from operations for the quarter stood at Rs 89.32 crore, while total income reached Rs 91.35 crore. Profit before tax followed a similar trajectory, rising 64% to Rs 18.60 crore.
Why this matters
The results demonstrate the company's ability to capitalize on market demand within its specific segment. A 52% year-on-year revenue increase paired with a 57% rise in net profit indicates that the company is effectively managing its scale and operational costs despite the higher expense base of Rs 72.75 crore recorded for the quarter.
The backstory
For the first half of the fiscal year (H1 FY2027), Paushak has maintained consistent momentum. Revenue for the half-year touched Rs 172.87 crore, a 51% increase over the Rs 114.66 crore reported in H1 FY2026. Profit after tax for the six-month period stands at Rs 28.62 crore, marking a 39% growth over the previous year.
What to track next
As Paushak operates exclusively in the specialty chemicals industry, investors should monitor sector-specific input cost fluctuations and demand consistency in international and domestic markets. The company’s ability to sustain these double-digit growth margins amid changing global chemical pricing will be the primary metric for long-term valuation.
